政大機構典藏-National Chengchi University Institutional Repository(NCCUR):Item 140.119/109600
English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  全文笔数/总笔数 : 109952/140903 (78%)
造访人次 : 46051821      在线人数 : 897
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻


    请使用永久网址来引用或连结此文件: https://nccur.lib.nccu.edu.tw/handle/140.119/109600


    题名: Destroying a Pharmaceutical Patent for Saving Lives? A Case Study of Sanofi-Synthelabo v. Apotex, Inc.
    作者: 陳秉訓
    Chen, Ping-Hsun
    贡献者: 科智所
    关键词: Abbreviated New Drug Application;antitrust;patent;generic drug
    日期: 2011-01
    上传时间: 2017-05-15 15:48:40 (UTC+8)
    摘要: In Sanofi-Synthelabo v. Apotex, Inc., both parties once intended to end the war. Maybe because the market of Plavix® is less competitive, both parties tried to avoid the expensive trial. Apotex was not worried about losing the exclusivity period, while Bristol-Myers Squibb thought of maintaining the monopoly. The antitrust law intervened to stop the scenario, which resulted in the indictment of the former vice president of Bristol-Myers Squibb. Though Apotex went on to fight against the patent as what the Act expected, Apotex finally lost. The drug market remained the same, and there have been no upcoming generic drug companies which want to challenge the patent at dispute. Definitely, the Act seems to underestimate the strength of brand-name drug patents and other negative impacts unnecessary patent litigation might give.
    關聯: Albany Law Journal of Science and Technology, Vol.21, No.1, pp.125-152.
    数据类型: article
    显示于类别:[科技管理與智慧財產研究所] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML2492检视/开启


    在政大典藏中所有的数据项都受到原著作权保护.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏，無償提供學術研究與公眾教育等公益性使用，惟仍請適度，合理使用本網站之內容，以尊重著作權人之權益。商業上之利用，則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作，已盡力防止侵害著作權人之權益，如仍發現本網站之數位內容有侵害著作權人權益情事者，請權利人通知本網站維護人員(nccur@nccu.edu.tw)，維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈